Patents by Inventor David Givol

David Givol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
    Patent number: 6217866
    Abstract: Hybridoma cell lines producing monoclonal antibodies specific to the human epidermal growth factor receptor are disclosed. The antibodies are capable of inhibiting the growth of human tumor cells expressing human epidermal growth factor receptors. Therapeutic uses of these monoclonal antibodies by themselves and in combination with anti-neoplastic agents are also disclosed.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 17, 2001
    Assignee: Rhone-Poulenc Rorer International (Holdings), Inc.
    Inventors: Joseph Schlessinger, David Givol, Francoise Bellot, Richard Kris, George A. Ricca, Christopher Cheadle, Victoria J. South